The potential of nonterminal cellular differentiation to stably repress the expression of the neoplastic phenotype of transformed cells is established. Nonterminal differentiation induces spontaneously transformed 3T3 T cells to revert to a nontransformed state and induces the revertant cell clones to become resistant to retransformation by UV irradiation or 4-nitroquinoline oxide treatment. Nonterminal differentiation also induces simian virus 40-transformed 3T3 T cells to repress expression of the large tumor antigen and to revert to a nontransformed state. Although the molecular mechanisms that mediate these and other forms of anticancer activity have not been definitively established, data are presented which suggest that differentiation-induced repression of large tumor antigen expression can be regulated at the level of transcription and/or RNA processing.
Carcinogenesis is a complex process that involves the development of multiple defects in the integrated control of cell proliferation and differentiation. Clinical and experimental observations suggest that during carcinogenesis defects must also develop in intrinsic cellular mechanisms that serve to antagonize the process of carcinogenesis (1) (2) (3) (4) (5) (6) (7) (8) . These have been designated by a variety of terms, which include antioncogenesis, recessive oncogenesis, tumor suppression, carcinogen resistance, cancer reversion, and others (1) (2) (3) (4) (5) (6) (7) (8) . In this paper, they are all described by the general term anticancer activity.
Many questions about anticancer activity exist. How is the expression of anticancer activity regulated? What intrinsic cellular mechanisms function to mediate resistance to carcinogenesis and to make transformed cells revert to a nontransformed state? How many different types of anticancer activity are there?
The existence of anticancer activity is supported by a variety of observations including those showing that normal human cells are highly resistant to experimental in vitro carcinogenesis (1, 2) and produce nontumorigenic cell hybrids when fused to transformed tumorigenic cells (3) . The inactivation or deletion of purported anticancer genes and their products has also been implicated in the genesis of several human cancers (4) and may represent a more general phenomenon. In addition, it has been demonstrated experimentally that the implantation of cancer cells into specific embryonic microenvironments can stably repress expression of the neoplastic phenotype (4) (5) (6) (7) (8) .
The biological and molecular mechanisms that regulate and/or mediate anticancer activity remain unknown; however, a variety of experimental observations suggest a possible role for cellular differentiation. Nontumorigenic cell hybrids developed by the fusion of normal human keratinocytes and HeLa cells when placed in vivo appear to differentiate in association with expression of anticancer activity (3) . The implantation of malignant embryonal carcinoma cells (6) , neuroblastoma cells (7), or acute myelogenous leukemia cells (8) into specific sites in the blastocyst or embryo stably inhibits their tumorigenic potential in association with the induction of apparent differentiation. The process of normal embryological differentiation in vivo also decreases the transformation proclivity of melanocyte stem cells (5 (9, 10) . JW16 and JW25 cells are spontaneously transformed derivatives of 3T3 T cells (11) . Finally, CSV3-1 represents a clonal cell line that was derived by transfection of pSV3-neo DNA (12) into 3T3 T cells followed by selection for geneticin (G418) resistance. In their native state, CSV3-1 cells are transformed and grow in soft agar and they express the SV40 T antigen. The biological and molecular characteristics of CSV3-1 cells will be described in more detail elsewhere (D.N.E., P.M., C.-Y.T. and R.E.S., unpublished observations Eagle's medium (DMEM) containing 10%o fetal bovine serum according to standard procedures (9) (10) (11) .
Growth Arrest and Nonterminal Differentiation. These cell lines possess the potential to arrest their growth under one or more culture conditions and/or to differentiate into adipocytes. Serum deficiency-associated growth arrest was induced in some of these cell lines by culture in DMEM containing 0.5% fetal bovine serum for 3-5 days. Predifferentiation growth arrest and subsequent adipocyte differentiation of all these cell lines was induced by culture in heparinized DMEM containing 25% human plasma or a human plasma fraction (CEPH) on bacteriologic Petri dishes for 5-8 days. The assays used to evaluate growth arrest include measurement of [3H]thymidine incorporation into DNA and flow microfluorometry; the assays used to evaluate adipocyte differentiation by phase microscopy have previously been described in detail (13) (14) (15) (16) .
Cell Cloning. A microchip procedure was used to clone individual undifferentiated or differentiated cells as described (17) . Cells were then refed DMEM containing 30o fetal bovine serum plus insulin (50 pug/ml) to induce clonal cell growth.
Neoplastic Transformation Assays. Two types of in vitro transformation assays were used. These included the type III foci assay and the soft agar growth assay. Both were performed according to published procedures (18, 19) . Type III foci assays to measure anchorage-independent growth were performed in a monolayer culture microenvironment in the presence of DMEM plus 10% fetal bovine serum for 21 days. Soft agar assays to measure anchorage-independent growth were performed in suspension in agarose in DMEM plus 30% fetal bovine serum + insulin (50 pg/ml) for 14 days.
Cell Transfection with pSV3 DNA and Detection of SV40 T Antigen. Transformed geneticin-resistant clones of BALB/c 3T3 T cells that express the SV40 T antigen were developed by the transfection of pSV3-neo DNA (12) into cells (5 ,tg of DNA per 2.5 x 105 cells) by the method of Graham and van der Eb (20) followed by the subsequent selection for geneticin (G418) resistance. Detection of SV40 T antigen primarily employed immunofluorescence using a T-antigen-specific monoclonal antibody (Oncogene Sciences, Mineola, NY). Western blotting procedures were also used in some studies to evaluate T-antigen expression.
Cell Transfection with pSV2-cat DNA and Detecfion of Chloramphenicol Acetyltransferase (CAT) Activity. Rapidly growing 3T3 T cells were transfected with pSV2-cat DNA (10 ,ug of DNA per 1.5 x 106 cells) as described (21) . Thirty-six hours thereafter, rapidly growing specimens were passaged into two groups by dissociation with medium containing trypsin and EDTA. One group was placed in differentiationpromoting medium (heparinized DMEM plus 25% human plasma) and the other was cultured in growth factor-deficient medium (DMEM plus 0.5% fetal bovine serum) to induce growth arrest in an undifferentiated state. Under these culture conditions, each specimen underwent =w1 population doubling before growth arrest.
At identical times thereafter, typically 5-7 days after passage, each specimen was assayed for the relative expression of CAT activity by standard procedures (21). The procedure described above establishes that both undifferentiated and differentiated specimens had to contain a comparable quantity of pSV2-cat DNA. The percentage CAT metabolized was quantitated by use of the AMBIS Radioanalytic Imaging Computer System. In these assays, equal numbers of cells were used.
RESULTS
Model Cell System to Evaluate Differentiation-Induced Anticancer Activity. The BALB/c 3T3 T mesenchymal stem cell system provides an excellent model to study the regulation of anticancer activity. Native 3T3 T cells are nontransformed and nontumorigenic (9, 10) and they possess the ability to integrally regulate their proliferation and differentiation at a variety of biological states. Fig. 1 illustrates that the differentiation of 3T3 T cells into adipocytes involves three distinct steps: (i) reversible growth arrest at a distinct predifferentiation state, (ii) nonterminal differentiation, and (iii) terminal differentiation. 3T3 T cells can also reversibly arrest growth due to growth factor or serum deficiency but cannot differentiate from this state (13) (14) (15) (16) (17) . Most important for the current studies, the 3T3 T-cell model system also includes spontaneously transformed 3T3 T-cell clones-i.e., JW16 and JW25 cell clones-and SV40-transformed 3T3 T cells. JW16 and JW2S-3T3 T cells retain the potential to nonterminally differentiate into adipocytes, even though at a reduced frequency-i.e., 10-50% of that evident in native 3T3 T cells (11) . The SV40-transformed cell line designated CSV3-1 also has the potential to nonterminally differentiate into adipocytes and does so almost as efficiently as native 3T3 T cells.
The availability of these cell lines makes possible the current studies to determine whether the expression of a nonterminally differentiated phenotype can induce cancer cells to revert to a nontransformed state and to become resistant to retransformation.
Nonterminal Differentiation Induces Spontaneously Transformed Cells to Revert to a Nontransformed State and to Become Resistant to Retransformation. Experiments were first performed to determine whether completely transformed JW16 and JW25 3T3 T cells (11) can be made to revert to a nontransformed state by induction of nonterminal adipocyte differentiation. Both of these cell lines are tumorigenic in vivo and express a transformed phenotype in vitro as demonstrated by their ability to grow and form colonies in soft agar and to produce type III foci in high-density monolayer cultures (11) . Both cell lines also demonstrate a saturation density in medium containing 10o fetal bovine serum that is nearly 3 times greater than nontransformed cells.
Clones To determine whether such revertant cell clones were resistant to retransformation, they were next treated with UV irradiation (90 ergs/mm2) or 4-nitroquinoline oxide (4NQO) (100 ng/ml) for 24 hr as described (22) . The data in Table 2 and Fig. 2 in heparinized DMEM containing 25% human plasma or specific human plasma fractions.
The initial experiments were performed with these cells to evaluate whether nonterminal adipocyte differentiation represses expression of the SV40 T antigen and concomitantly induces reversion to a nontransformed state. The data in Fig.  3 Fig. 4 indeed show that within 48-72 hr after serum stimulation of CSV3-1 adipocytes, T antigen is reexpressed in the vast majority of adipocytes, even though they continue to show repression of anchorage-independent growth. To prove that maintenance in soft agar for extended intervals did not induce terminal differentiation as a mechanism of repression of anchorage- independent growth, cells were isolated from the suspension microenvironment and placed in a monolayer culture and .85% of the cells thereafter grew and formed colonies in medium containing 30o fetal bovine serum plus insulin (50 pug/ml).
The final series of studies that were performed with CSV3-1 cells evaluated the stability of the differentiationinduced repression of anchorage-independent growth. For these experiments, nonterminally differentiated adipocytes were isolated and cultured in a monolayer microenvironment in DMEM containing 30o fetal bovine serum plus insulin (50 ,ug/ml). After various numbers of population doublings, determined microscopically by colony size, cloning rings were used to isolate small groups of cells that were then placed in soft agar to evaluate their ability to grow in an anchorage-independent mode. In control studies using a comparable procedure, rapidly growing undifferentiated cells showed >99% colony-forming efficiency.
The result of these studies established that differentiationinduced repression of anchorage-independent growth was stable in -80% ofthe cells for 5 population doublings and was stable in -15% of the cells for 20 population doublings. After 30 population doublings, essentially all cells had acquired the ability to grow in soft agar and had therefore lost this form of anticancer activity. These observations complement those reported above on transformed JW 3T3 T cells and establish that nonterminal differentiation can stably induce reversion of the transformed phenotype and resistance to spontaneous or induced retransformation. A Possible Mechanism for Differentiation-Induced Anticancer Activity. Nonterminal differentiation has been documented above to induce multiple forms ofanticancer activity. A most important question in this regard concerns the molecular mechanisms that might mediate these processes and specifically whether nonterminal differentiation induces anticancer activity by transcription, posttranscription, translational, or posttranslational mechanisms.
To begin to investigate this question, the pSV2-cat plasmid (21) , which contains SV40 regulatory sequences that control the transcription of the marker enzyme CAT, was transiently transfected into rapidly growing specimens of 3T3 T cells. Such specimens were then split into two groups; one was induced to undergo growth arrest and differentiation by culture in heparinized DMEM containing 25% CEPH and another group was induced to undergo growth arrest in an undifferentiated state by culture in DMEM containing 0.5% serum. Cells in both specimens underwent =1.0 population doubling prior to growth arrest, and thereafter the relative activity of CAT was assayed.
The purpose of this experimental design was to determine whether adipocyte differentiation selectively represses the activity of pSV2 regulatory sequences that control the expression of CAT in a manner comparable to the suppression of T-antigen expression. The data in Table 3 confirm this possibility and show that in differentiated cells CAT activity is repressed by .85% compared to that observed in growtharrested undifferentiated cells. These results were reproduced in six experiments. It must be emphasized that the procedure used to transfect these specimens ensures that both undifferentiated and differentiated specimens contained comparable quantities of pSV2-cat DNA. In support of this conclusion, it was also found that the level of CAT activity in differentiated cells could be restimulated within 25 hr to levels present in undifferentiated cells by induction of proliferation of the adipocytes with DMEM plus 30% fetal bovine serum plus insulin (50 pug/ml) (data not shown).
Since the expression of two genes-i.e., SV40 T antigen and CAT-that are both controlled by the same SV40 regulatory sequences is similarly repressed by adipocyte differentiation, these data suggest that differentiation probably mediates this effect at the level oftranscription, although it is not absolutely possible to exclude an effect on RNA processing. Additional results demonstrated that differentiation does not, however, repress CAT activity that is controlled by Rous sarcoma virus (RSV) regulatory sequences. The latter data rule out the possibility that a posttranscriptional effect of differentiation might mediate modulation of pSV2-cat activity because pRSV-cat and pSV2-cat are identical except in their regulatory sequences.
DISCUSSION
The expression of defects in the control of cell proliferation and differentiation can lead to development of anaplastic rapidly growing cancer cells (23) . However, some cancer cells proliferate very slowly (23, 24) and some cancer cells retain the potential to differentiate extensively (23, 25) . These observations suggest that the expression of highly aberrant proliferation and differentiation characteristics might not be all that is required for a cell to be malignant. What additional defects might cells have to develop before they become malignant? One possibility is that cancer cells might have to express partial or complete defects in intrinsic cellular anticancer mechanisms.
Experimental evidence that supports the existence of anticancer mechanisms has been derived from a variety of different experimental approaches. These include studies that used the fusion of normal and malignant cells (3) , the implantation of cancer cells into specific embryonic microenvironments (6) (7) (8) , and the treatment of cancer cells with biological response modifiers (26) . The results of these studies suggest that multiple forms ofanticancer activity exist as do multiple complementation groups of anticancer genes, some of which have already been localized to specific chromosomes (3) . Furthermore, these studies imply that the process of differentiation might be involved in anticarcinogenesis.
The current experiments were therefore designed to investigate whether differentiation-dependent processes serve to regulate the expression of anticancer activity. Since multiple types of anticancer activity appear to exist, we used two different experimental systems to study specifically whether the process ofnonterminal differentiation induces the expression of anticancer activity. The 
